Simple Summary Many head-and-neck cancer patients assigned to chemoradiation cannot
receive concurrent cisplatin due to impaired renal function. Carboplatin may be an …

Purpose Patients with synchronous metastatic head and neck squamous cell carcinomas
often present associated locoregional symptoms and a risk of life-threatening primary …

Objectives Concurrent chemoradiotherapy is standard of care in locally advanced
oropharyngeal cancer (LA-OPC). This treatment regimen results in significant acute …

Objectives: Radiological extranodal extension (rENE) upon CT is obtained before
concurrent chemoradiation therapy (CCRT) for head and neck squamous cell carcinoma …

Malignant tumors such as squamous cell carcinoma (SCC), malignant salivary gland tumor,
mucosal melanoma, sarcoma, and lymphoma occur in the oral cavity. Among them, oral …

Purpose Radiochemotherapy (RCT) is an effective standard therapy for locally advanced
head and neck squamous cell carcinoma (LA-HNSCC). Nonetheless, toxicity is common …

Objective To assess the feasibility in routine practice of postoperative chemoradiotherapy in
head and neck squamous cell carcinoma (HNSCC) at high risk of recurrence. Method A …

Background: Based on previous observations that the nutraceutical CELLFOOD™(CF), the
'physiological modulator'that aimed to make oxygen available 'on demand', inhibits the …

Résumé Objectif Évaluer en pratique quotidienne la faisabilité de la radiochimiothérapie
postopératoire chez les patients traités pour un carcinome épidermoïde des voies …

Concurrent chemoradiotherapy plays a vital role in the treatment of locally advanced
squamous cell carcinoma of the oropharynx (LA-OPC). Importantly, only 50-85% of patients …